Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Name: Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology
SKU: 3245
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 36 No. 1 Articles Tags: aliou-d-ousmanou, drug-interactions, drug-transport-protein, inducer, inhibitor, multidrug-resistance, p-glycoprotein, sheri-l-hoyler, stanley-w-carson, substrate

Description

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

David M. Lyons, PhD: Stress, Depression, and Inherited Variation in Primate Hippocampal and Prefrontal Brain Development

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles

Psychotropic Drug Interactions: A Doctor’s Guide

Stanley W. Carson, PharmD, FCCP, BCPP: Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Description

Stanley W. Carson

DRUG INTERACTIONS

Emerging Significance of P-glycoprotein in Understanding Drug Disposition and Drug Interactions in Psychopharmacology

Stanley W. Carson, PharmD, FCCP, BCPP, Aliou D. Ousmanou, PharmD, and Sheri L. Hoyler, PharmD

Related products

David M. Lyons, PhD: Stress, Depression, and Inherited Variation in Primate Hippocampal and Prefrontal Brain Development

Karen Dineen Wagner, MD, PhD: Management of Treatment Refractory Attention-Deficit/Hyperactivity Disorder in Children and Adolescents

The Prescriber’s Guide to the MAOI Diet—Thinking Through Tyramine Troubles

Psychotropic Drug Interactions: A Doctor’s Guide